Navigation Links
European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
Date:12/17/2007

.S. prescribing information, including Boxed WARNINGS, for ATRIPLA, visit http://www.atripla.com. For complete prescribing information for SUSTIVA, visit http://www.bms.com. For complete U.S. prescribing information for Truvada, Viread and Emtriva, including Boxed WARNINGS, visit http://www.gilead.com.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global pharmaceutical and related healthcare products company. Visit Bristol-Myers Squibb on the World Wide Web at http://www.bms.com.

About Gilead Sciences

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life- threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia. Visit Gilead on the World Wide Web at http://www.gilead.com.

Forward-Looking Statements

Bristol-Myers Squibb Forward-Looking Statement

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995 regarding the marketing of ATRIPLA in Europe. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including factors that could delay, divert or change any of them, and could cause actual outcomes and results to differ materially from current expectations. No forward-looking statement can be guaranteed. Among other risks, there can be no guarantee that the timing of the launch of ATRIPLA will occur in Europe as described in this release or that ATRIPLA will be commercially successful in Europe.
'/>"/>

SOURCE Bristol-Myers Squibb Company
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
3. European Experts Recommend Pregnant and Nursing Women Take More DHA - Every Day
4. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
5. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
6. Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO)
7. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
8. Life Recovery Systems Receives European CE Mark Approval for Its ThermoSuit(R) System
9. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
10. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
11. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...re/ -- Depression, anxiety disorder, bipolar disor...D), sleep disorder and migraine: These are among t...eople who said they had been diagnosed with epilep...ording to a survey of approximately 173,000 househ...ated Comorbidities in Individuals with Self-Report...
(Date:12/3/2009)...re-FirstCall/ -- A genetic variation that may indi...life-threatening blood disorder if exposed to cert...f several medical discoveries scientists at cancer... ) will present during the 51st American Society o...December 5-8, 2009, in New Orleans, LA. ,, In ...
(Date:12/3/2009)...3 Radiology imaging leader MEDRAD,...ion capabilities at the November 2009 Radiology So...ACS(TM) product, enabling the first radiology inf...elease in the company,s newly branded Certegra(TM...www.newscom.com/cgi-bin/prnh/20091203/NE20631 ) ,...
Breaking Medicine Technology:Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3Video 3A Worksite Wellness Programs Lower Healthcare Costs Make Employees Healthier 58577 1Video 3A Worksite Wellness Programs Lower Healthcare Costs Make Employees Healthier 58577 2Video 3A Worksite Wellness Programs Lower Healthcare Costs Make Employees Healthier 58577 3Video 3A Worksite Wellness Programs Lower Healthcare Costs Make Employees Healthier 58577 4Heartland Information Services Appoints New Chief Executive Officer 58575 1Heartland Information Services Appoints New Chief Executive Officer 58575 2Stimulus Grant To Fund Whole Genome Sequencing In Children With Autism 14303 1Stimulus Grant To Fund Whole Genome Sequencing In Children With Autism 14303 2Stimulus Grant To Fund Whole Genome Sequencing In Children With Autism 14303 3Stimulus Grant To Fund Whole Genome Sequencing In Children With Autism 14303 4
...s Major Corporate Milestone and Advances ...ich., July 17 Meditrina Pharmaceuticals,Inc. toda...onal new drug,(IND) application for a Phase IIb do...mpany,s aromatase inhibitor (AI), in combination w...dometriosis. MPI-676 is the,newest addition to Med...
... compares favorably to data from other, technolog...rstCall/ - Bradmer Pharmaceuticals Inc.,(TSX: BMR)...elopment and,commercialization of cancer therapies...ata from two previously conducted Phase II trials ...patients. As an exploratory,endpoint of the single...
Other Medicine Technology:Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial With MPI-676 in Endometriosis 2Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial With MPI-676 in Endometriosis 3Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial With MPI-676 in Endometriosis 4Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials 2Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials 3Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials 4Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials 5
(Date:12/4/2009)...OKE, Bermuda, Dec. 4 All... AWH ) today announced that Scott Carmilani,Presi..., Executive Vice,President and Chief Corporate Str...man Sachs U.S. Financial Services Conference being...w York City on Tuesday, December 8, 2009. ,, ...
(Date:12/4/2009)...DISON HEIGHTS, Mich., Dec. 4 The E...of BetterInvesting Magazine today announced All...Stock to Study" and C.R. Bard, Inc. (NYSE: BCR...vestors, informational and educational use. ,, ...portunities involving its flagship drug Botox and ...
(Date:12/4/2009)...risk for some pediatric cancers, particularly Ewin...m, according to a new study published online Decem...tute . , This study was undertaken because there...ears and up to 20 years) for pediatric cancer pati...lac Cancer Center and Blood Disorders Service, Chi...
(Date:12/4/2009)...n Americans are recruited annually to participate ...uman Research Protection (AHRP), and most will be ...rch institutions view payments to volunteers as co...ion for potential risks related to participating i...unteers have a very different view of clinical tri...
(Date:12/4/2009)...ter and fruit consumption leads to success, study...ews) -- Increased exercise, reduced soda consumpti...weight control strategies for adolescents, a new s...nts about their weight-control strategies and life...ight and 68 had not. The responses were grouped in...
Breaking Medicine News(10 mins):Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:Human guinea pigs wary of high-paying medical trials 2Health News:Teens Lose More Weight Using Healthy Strategies 2
... AHF,s First in Kenya, is US AIDS Group,s 39th Glo...ide. New Kenyan Partnership Will, Provide Life- sa...ombasa, Kenya, where the National HIV/AIDS ...Institute (KEMRI) to help save lives in Kenya by p...
...H, Oct. 3 Knopp Neurosciences Inc. ("Knopp"),anno... joined the company,as senior vice president of re.../www.newscom.com/cgi-bin/prnh/20070924/KNOPPLOGO ... Administration and responsibility for global regu...
... Success Rate for Catheter Ablation Procedures Per...ty of Cardiology Congress, ST. LOUIS, Oct. 3 Ste...resentation by Xu Chen, M.D., of the,Rigshospitale...ation system. Dr. Chen presented the data at the r...
...alif., Oct. 3 /PRNewswire/ Awakening(R) Mineral Th... naturally mineral-rich skin care,products, is sli...eness,Month. A maximum of 20 spas and salons acros...e follicle roots and scalp tissue. "An Awakening S...
...y acquisition announced at the opening of Eurospin...ssels, HUNTERSVILLE, N.C., Oct. 3 Orthofix,Inter... announced it has,acquired the rights to all of th...dividuals with lumbar spinal stenosis (LSS). The i...
...on, ON (Oct. 1, 2007) Lower muscle mass and an in...ing older. , While exercise is a proven way to p... McMaster researcher Dr. Mark Tarnopolsky shows th...ater benefits. , The study to be published on O...
Other Medicine News:Health News:AHF and Kenya Medical Research Institute Partner to Save Lives at Free AIDS Treatment Clinic in Mombasa 2Health News:AHF and Kenya Medical Research Institute Partner to Save Lives at Free AIDS Treatment Clinic in Mombasa 3Health News:Cheryl Fossum Graham Joins Knopp Neurosciences as Head of Regulatory and Development Strategy 2Health News:Cheryl Fossum Graham Joins Knopp Neurosciences as Head of Regulatory and Development Strategy 3Health News:Stereotaxis Highlights New Data on Acute Success in AFib Treatments With Niobe Magnetic Navigation System 2Health News:Stereotaxis Highlights New Data on Acute Success in AFib Treatments With Niobe Magnetic Navigation System 3Health News:California Company Slings Mud for Breast Cancer Awareness 2Health News:Orthofix International Acquires InSWing(TM) Interspinous Process Spacer 2Health News:Orthofix International Acquires InSWing(TM) Interspinous Process Spacer 3
...ion nebulizer achieves optimum lung penetration fo...ticle size range is 1.04-1.10 µ at 6-8 LPM. ...ir outlet., ,As the world leader in airway manage...the assurance of proven technology by offering top...
...rough continuous low-flow nebulizer performance. P...nology allows for optimal medication and Heliox de...s on severe asthma, COPD and pneumonia in both rou...a mask, mouth and T-piece to deliver high-output, ...
...bulizers offer a spill-proof design and effective ...l medical nebulizers are free-standing for easy pr... available., ,All Portex® medication nebulize...ion nebulizers feature consistently fine misting a...
...bulizers offer a spill-proof design and effective ...l medical nebulizers are free-standing for easy pr... available., ,All Portex® medication nebulize...ion nebulizers feature consistently fine misting a...
Medicine Products: